Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_assertion description "[Preexposure of the glioma cell lines to the cytokines, IFN gamma and TNF alpha, which sensitize for Fas/APO-1-dependent killing, partially overcame bcl-2-mediated rescue from apoptosis, suggesting that multimodality immunotherapy involving cytokines and Fas/APO-1 targeting might eventually provide a promising approach to the treatment of human malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_assertion evidence source_evidence_literature NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_assertion SIO_000772 7539458 NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_assertion wasDerivedFrom befree-20140225 NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_assertion wasGeneratedBy ECO_0000203 NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.
- befree-20140225 importedOn "2014-02-25" NP709214.RAgU968OPGX6E1fprNh4zew3NKcT7Y08RXsC32R_GWy0w130_provenance.